{"nct_id":"NCT05017012","title":"A Study to Evaluate the Bioavailability of Pembrolizumab (MK-3475) Via Subcutaneous (SC) Injection of Pembrolizumab Formulated With Berahyaluronidase Alfa (MK-5180) [MK-3475A] In Advanced Solid Tumors (MK-3475A-C18)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-12","start_date":"2021-09-21","start_date_type":"ACTUAL","primary_completion_date":"2026-09-26","primary_completion_date_type":"ESTIMATED","completion_date":"2026-09-26","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["MRK"]}